[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Safaa Ali\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":14,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":19,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100601641",false,"NCT07113132","Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia","Inclusion Criteria:\n\n* Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.\n\nExclusion Criteria:\n\n* Patients with any other type of malignancies",true,"ALL",{"count":17,"type":18},84,"ESTIMATED","6 Months","OBSERVATIONAL","aim of the work\n\n1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia.\n2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.",[23,24],"Acute Lymphoblastic Leukemia ALL","Chronic Lymphocytic Leukemia (CLL)",[26,27,28],"sf3b1 mutation","all","cll","NOT_YET_RECRUITING","2025-08-06",{"date":32,"type":33},"2025-08-08","ACTUAL",{"date":35,"type":18},"2025-08-01",{"date":37,"type":18},"2027-07-01",{"name":39,"class":40},"Safaa Ali","OTHER",""]